Search Results - "Rimar, D"

Systemic sclerosis, silica exposure and cellular therapies: The sand in the gears? by Lescoat, A., Rimar, D., Farge, D.

“…Systemic sclerosis (SSc) is a chronic orphan autoimmune disease with the highest mortality rate among rheumatic diseases. SSc-related interstitial-lung disease…”
Get full text

Von Willebrand factor: a possible biomarker for disease activity in vasculitis by Keret, S, Mazareeb, J, Snir, A, Shouval, A, Awisat, A, Kaly, L, Rosner, I, Rozenbaum, M, Boulman, N, Hardak, E, Slobodin, G, Rimar, D

“…Inflammation markers, e.g. C- reactive protein (CRP) and sedimentation rate, can be normal despite active vasculitis. Von Willebrand factor (vWF) is secreted…”
Get full text

Nosocomial multi-drug resistant Acinetobacter baumannii bloodstream infection: risk factors and outcome with ampicillin-sulbactam treatment by Smolyakov, R, Borer, A, Riesenberg, K, Schlaeffer, F, Alkan, M, Porath, A, Rimar, D, Almog, Y, Gilad, J

“…The emergence of multidrug-resistant (MDR) Acinetobacter baumannii poses a therapeutic problem. The aim of this study was to assess the risk factors for…”
Get full text

Semaphorin 3A, a potential immune regulator in Familial Mediterranean Fever by Rimar, D, Rosner, I, Slobodin, G, Boulman, N, Kaly, L, Rozenbaum, M, Vadasz, Z

Get full text

Variant CAPS in an adult- the use of genetics by Rozenbam, M, Rimar, D, Kaly, L, Slobodin, G, Awisat, A, Rosner, I

Get full text

Anti-tumor necrosis factor treatment and pregnancy: the way is open by Boulman, N, Rimar, D, Rozenbaum, M, Slobodin, G, Younis, S, Rosner, I

Get full text

The role of regulatory T cells in familial Mediterranean fever (FMF) by Rimar, D., Rosner, I., Slobodin, G., Boulman, N., Toubi, E., Kessel, A., Peri, R., Rozenbaum, M.

“…The role of regulatory T cells (T-regs) in familial Mediterranean fever (FMF) was never evaluated. Preliminary studies that we have conducted suggested a rise…”
Get full text

1039 IS FAMILIAL MEDITERRANEAN FEVER (FMF) ASSOCIATED WITH NON-ALCOHOLIC FATTY LIVER DISEASE (NAFLD)? by Rimar, D, Rosner, I, Rozenbaum, M, Zuckerman, E

Get full text

Rheumatology Education in Europe: results of a survey of young rheumatologists by BANDINELLI, F, BIJLSMA, J. W. J, MAYER, M, DUARTE MARQUES, C. C, DA SILVA, J. A. P, CUTOLO, M, RAMIRO, M. S, ELFVING, P, GOEKOOP-RUITERMAN, Y. P. M, SIVERA, F, MOLTO REVILLA, A, MARINESCU, C, RIMAR, D, NORKUVIENE, E

“…To evaluate the level of education and participation in an internship abroad and to European league against rheumatism (EULAR) on line course of young…”
Get full text

Indications for a “Surgery-First” Approach for the Treatment of Lower Extremity Arterial Disease by Kumar, Mohineesh, Long, Graham W., Rimar, Steven D., Studzinski, Diane M., Callahan, Rose E., Brown, O. William

“…In recent years, there has been a tendency toward an “endovascular-first” approach for the treatment for femoropopliteal arterial disease. The purpose of this…”
Get full text

Improved prognosis of patients presenting with clinical markers of spontaneous reperfusion during acute myocardial infarction by Rimar, D, Crystal, E, Battler, A, Gottlieb, S, Freimark, D, Hod, H, Boyko, V, Mandelzweig, L, Behar, S, Leor, J

“…Objective: To describe the clinical features, management, and prognosis of patients presenting with clinical markers of spontaneous reperfusion (SR) during…”
Get full text

Safety of Percutaneous Transfemoral Coronary and Peripheral Procedures Via Aortofemoral Synthetic Vascular Grafts by Gallagher, Michael J., Dixon, Simon R., Safian, Robert D., Madala, Mohan, Abraham, Renny, Rimar, Steven D., Mattichak, Stephen J., O’Neill, William W., Kahn, Joel K.

“…Our objective was to evaluate the safety of percutaneous transfemoral catheterization performed by way of synthetic aortofemoral vascular grafts. Between 1994…”
Get full text

Transrenal fixation of endovascular stent-grafts for infrarenal aortic aneurysm repair: Mid-term results by Bove, Paul G., Long, Graham W., Shanley, Charles J., Brown, O.W., Rimar, Steven D., Hans, Sachinder S., Kitzmiller, John W., Bendick, Phillip J., Zelenock, Gerald B.

“…Purpose: We evaluated mid-term results of a single-center consecutive series of endovascular stent-grafts implanted for aortic aneurysm repair with transrenal…”
Get full text

Outcomes of patients with systemic sclerosis treated with rituximab in contemporary practice: a prospective cohort study by Elhai, Muriel, Boubaya, Marouane, Distler, Oliver, Smith, Vanessa, Matucci-Cerinic, Marco, Alegre Sancho, Juan José, Truchetet, Marie-Elise, Braun-Moscovici, Yolanda, Iannone, Florenzo, Novikov, Pavel I, Lescoat, Alain, Siegert, Elise, Castellví, Ivan, Airó, Paolo, Vettori, Serena, De Langhe, Ellen, Hachulla, Eric, Erler, Anne, Ananieva, Lidia, Krusche, Martin, López-Longo, F J, Distler, Jörg H W, Hunzelmann, Nicolas, Hoffmann-Vold, Anna-Maria, Riccieri, Valeria, Hsu, Vivien M, Pozzi, Maria R, Ancuta, Codrina, Rosato, Edoardo, Mihai, Carina, Kuwana, Masataka, Saketkoo, Lesley Ann, Chizzolini, Carlo, Hesselstrand, Roger, Ullman, Susanne, Yavuz, Sule, Rednic, Simona, Caimmi, Cristian, Bloch-Queyrat, Coralie, Allanore, Yannick

“…To assess the safety and efficacy of rituximab in systemic sclerosis (SSc) in clinical practice. We performed a prospective study including patients with SSc…”
Get more information

Phenotypes Determined by Cluster Analysis and Their Survival in the Prospective European Scleroderma Trials and Research Cohort of Patients With Systemic Sclerosis by Allanore, Yannick, Riemekasten, Gabriela, Vettori, Serena, Matucci‐Cerinic, Marco, Launay, David, Walker, Ulrich, Lapadula, Giovanni, Sierakowsky, Stanislaw, Siegert, Elise, Nicoara, Ileana, Kahan, André, Carreira, Patricia E., Novak, Srdan, Varju, Cecilia, Chizzolini, Carlo, Widuchowska, Malgorzata, Rozman, Blaz, Mallia, Carmel, Wu, Chen, Hij, Darin, Dhamadi, Roza, Wollheim, Frank, Wuttge, Dirk M., Andréasson, Kristofer, Martinovic, Duska, Balbir‐Gurman, Alexandra, Braun‐Moscovici, Yolanda, Lo Monaco, Andrea, Caramaschi, Paola, Henes, Jörg, Santamaria, Vera Ortiz, Heitmann, Stefan, Krasowska, Dorota, Himsel, Andrea, Da Silva, José Antonio Pereira, Stamenkovic, Bojana, Tikly, Mohammed, Tarner, Ingo, Damgaard, Kirsten, Mendoza, Antonio Zea, Sifuentes Giraldo, WA, Midtvedt, Øyvind, Riccieri, Valeria, Ionescu, Ruxandra Maria, Opris, Daniela, Groseanu, Laura, Cornateanu, Roxana Sfrent, Ionitescu, Razvan, Gherghe, Ana Maria, Gorga, Marilena, Bojinca, Mihai, Distler, Jörg H. W., Beyer, Christian, Meroni, Pierluigi, Ingegnoli, Francesca, Mouthon, Luc, De Keyser, Filip, Smith, Vanessa, Corrado, Ada, Pozzi, Maria R., Eyerich, Kilian, Knott, Elisabeth, Wiland, Piotr, Szmyrka‐Kaczmarek, Magdalena, Morgiel, Ewa, Krummel‐Lorenz, Brigitte, Günther, Claudia, Souza Müller, Carolina, Azevedo, Valderílio F., Groppa, Liliana, Chiaburu, Lealea, Russu, Eugen, Zenone, Thierry, Stebbings, Simon, Highton, John, Stamp, Lisa, Solanki, Kamal, Doube, Alan, Loyo, Esthela, Li, Mengtao, Rosato, Edoardo, Amoroso, Antonio, Tanaseanu, Cristina‐Mihaela, Dumitrascu, Alina, Foti, Rosario, Chirieac, Rodica, Ancuta, Codrina, Villiger, Peter, Adler, Sabine, Rubio, Silvia Rodriguez, Exposito, Marta Valero, Chatelus, Emmanuel, Chifflot, Hélène, Butrimiene, Irena, Rugiene, Rita, Karpec, Diana, Montoya, Fabiana, Limonta, Massimiliano, Brucato, Antonio Luca, Spertini, François

“…Objective Systemic sclerosis (SSc) is a heterogeneous connective tissue disease that is typically subdivided into limited cutaneous SSc (lcSSc) and diffuse…”
Get full text

Semaphorin 3A, a potential immune regulator in familial Mediterranean fever by Rimar, Doron, Rosner, Itzhak, Slobodin, Gleb, Rozenbaum, Michael, Halasz, Katy, Jiries, Nizar, Kaly, Lisa, Boulman, Nina, Vadasz, Zahava

“…Semaphorin 3A (sema3A) plays a regulatory role in immune responses with effects on both T and B regulatory cells. Familial Mediterranean fever (FMF) is an…”
Get full text

Vaccination SARS-CoV-2 chez les patients atteints de sclérodermie systémique et traités par autogreffe de cellules souches hématopoïétiques, au nom du Groupe MATHEC-SFGM-TC by Biard, L., Pugnet, G., Cacciatore, C., Munia, I., Lansiaux, P., Le Maignan, C., Crichi, B., Urbain, F., Marjanovic, Z., Berthier, S., Rimar, D., Farge, D.

“…Le 27 décembre 2020, la mise en œuvre de la vaccination contre le SARS-CoV-2 est devenue disponible en France tout d’abord pour tous les patients…”
Get full text

Indications for a “Surgery First” Approach for the Treatment of Lower Extremity Arterial Disease by Kumar, Mohineesh, Rimar, Steven D., Long, Graham W., Studzinski, Diane, Brown, O.W.

Get full text

P01-009 – 2 years of colchicine IV in intractable FMF by Kaly, L, Boulman, N, Rimar, D, Slobodin, G, Rosner, I, Rozenbaum, M

Get full text

P01-010 – Anti-TNF agents in intractable FMF: four cases by Kaly, L, Rimar, D, Slobodin, G, Jiries, N, Rosner, I, Rozenbaum, M

Get full text